BofA/Merrill Lynch Upgrades Edwards Lifesciences (EW) to Buy
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $94.37 +2.59%
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $108.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Upgrades Silicom Ltd. (SILC) to Buy
- Nomura/Instinet Upgrades ANA Holdings Inc (9202:JP) (ALNPY) to Buy
- TD Cowen Upgrades BCE Inc. (BCE:CN) (BCE) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
